Alzheimer’s disease, traditionally seen as a brain-centric condition, may have systemic origins and can be accelerated through bone marrow transplants from donors with familial Alzheimer’s to healthy mice. A new study underscores the disease’s potential transmission via cellular therapies and suggests screening donors for Alzheimer’s markers to prevent inadvertent disease transfer.